MX2017003556A - Formas de dosificacion de fenilefrina de liberacion pulsada. - Google Patents

Formas de dosificacion de fenilefrina de liberacion pulsada.

Info

Publication number
MX2017003556A
MX2017003556A MX2017003556A MX2017003556A MX2017003556A MX 2017003556 A MX2017003556 A MX 2017003556A MX 2017003556 A MX2017003556 A MX 2017003556A MX 2017003556 A MX2017003556 A MX 2017003556A MX 2017003556 A MX2017003556 A MX 2017003556A
Authority
MX
Mexico
Prior art keywords
dosage forms
pulsed release
release phenylephrine
contain
phenylephrine
Prior art date
Application number
MX2017003556A
Other languages
English (en)
Inventor
K Anness Daren
John Dansereau Richard
BALAN Guhan
l ramsey David
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2017003556A publication Critical patent/MX2017003556A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Abstract

Una forma de dosificación de partículas múltiples que puede suministrar fenilefrina en dosis pulsadas controladas. La forma de dosificación puede contener una forma de liberación inmediata que puede contener fenilefrina o una sal de esta y una pluralidad de partículas de liberación retardada con un revestimiento que puede contener fenilefrina o sal de esta y un revestimiento sensible al pH.
MX2017003556A 2014-09-19 2015-09-18 Formas de dosificacion de fenilefrina de liberacion pulsada. MX2017003556A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462052594P 2014-09-19 2014-09-19
PCT/US2015/050894 WO2016044704A1 (en) 2014-09-19 2015-09-18 Pulsed release phenylephrine dosage forms

Publications (1)

Publication Number Publication Date
MX2017003556A true MX2017003556A (es) 2017-07-14

Family

ID=54207818

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003556A MX2017003556A (es) 2014-09-19 2015-09-18 Formas de dosificacion de fenilefrina de liberacion pulsada.

Country Status (9)

Country Link
US (2) US9795571B2 (es)
EP (1) EP3193845A1 (es)
CN (1) CN107148268A (es)
AU (1) AU2015317469B2 (es)
BR (1) BR112017005574A2 (es)
CA (1) CA2959186C (es)
MX (1) MX2017003556A (es)
RU (1) RU2017106028A (es)
WO (1) WO2016044704A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4300977A (en) 1978-10-24 1981-11-17 Karl Heinz Stiegler Machine for welding thermoplastic sheets
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5229131A (en) 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
DE19724696A1 (de) 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
US6372254B1 (en) 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
RU2236847C2 (ru) 1998-11-02 2004-09-27 Илан Корпорейшн, Плк. Композиции в виде множества частиц с модифицированным высвобождением
DE19859636A1 (de) 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
DE10013029A1 (de) 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
IT1318625B1 (it) 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
CN1700907A (zh) * 2002-09-28 2005-11-23 麦克内尔-Ppc股份有限公司 具有两个核和一个开口的改进释放剂型
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
WO2004062577A2 (en) 2003-01-03 2004-07-29 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
DE10353186A1 (de) 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
US20060280795A1 (en) 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
FR2891459B1 (fr) 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
CA2653955C (en) 2006-06-01 2015-10-27 Schering Corporation Pharmaceutical compositions for sustained release of phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
WO2007143158A2 (en) * 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
KR20090015103A (ko) * 2006-06-01 2009-02-11 쉐링 코포레이션 페닐에프린 펄스 방출 제형 및 약제학적 조성물
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
KR101571179B1 (ko) 2008-01-10 2015-11-23 에보니크 룀 게엠베하 증가된 맥동성 활성 물질 방출을 갖는 코팅된 제약학적 또는 건강기능성 제제
MX2009001925A (es) 2009-02-20 2010-08-20 Senosiain S A De C V Lab Composicion farmaceutica oral para uso en enfermedades respiratorias.
JP6173912B2 (ja) * 2010-09-20 2017-08-02 エスピーアイ ファーマ，インコーポレイテッド マイクロカプセル化プロセスおよび製品

Also Published As

Publication number Publication date
CA2959186A1 (en) 2016-03-24
US10376478B2 (en) 2019-08-13
AU2015317469A8 (en) 2017-03-23
RU2017106028A (ru) 2018-10-22
AU2015317469B2 (en) 2018-03-15
RU2017106028A3 (es) 2018-10-22
CN107148268A (zh) 2017-09-08
CA2959186C (en) 2020-03-24
EP3193845A1 (en) 2017-07-26
AU2015317469A1 (en) 2017-03-16
WO2016044704A1 (en) 2016-03-24
US20160081948A1 (en) 2016-03-24
US20180000752A1 (en) 2018-01-04
US9795571B2 (en) 2017-10-24
BR112017005574A2 (pt) 2017-12-12

Similar Documents

Publication Publication Date Title
IL267727B (en) Methods and systems for monitoring security and creating alerts
IL276690A (en) Neural microphysiological systems and methods for their use
GB201806521D0 (en) Computer-implemented methods and systems for validating tokens for blockchain-based cryptocurrencies
IL261595A (en) Advanced liquid processing methods and systems
EP3485237A4 (en) DOSE MEASUREMENT SYSTEMS AND METHODS
GB201804926D0 (en) Systems and methods of delivering products with unmanned delivery
SG11201708264PA (en) Methods and systems for carpooling
GB201717264D0 (en) Systems and methods for carpooling
SG10201606948XA (en) Item delivery management systems and methods
IL280687B (en) Suture delivery systems and methods
AU360162S (en) Housing for instance for an autoinjector
GB201721021D0 (en) Computer-implemented methods and systems
IL263110A (en) Combined treatment of notch and pd-1 or pd-l1 inhibitors
SG11201704498QA (en) Computing systems and methods
SG11201608483PA (en) Drug delivery systems and related methods of use
PL3215115T3 (pl) Usuwalne układy powłokowe i sposoby
HK1195995A2 (en) Electronic payment systems and electronic payment methods
SG11201606038SA (en) Aqueous surface coating composition and modified particles
EP3600549A4 (en) SYSTEM AND METHOD FOR PROVIDING RADIOTHERAPY
IL262032A (en) Tangled projectiles and methods of using them
GB2548905B (en) Systems and methods for RAN-WLAN aggregation
EP3183945A4 (en) Particle therapy systems, devices, and methods for beam transportation
EP3193567A4 (en) Beam delivery system and particle beam therapy device
SG10201406521TA (en) Methods and systems for secure online payment
SG10201406639UA (en) Event Processing Systems and Methods